Molecular Specification
| Compound type | Mitochondrial-derived peptide |
|---|---|
| Amino-acid length | 16 |
| Sequence | MRWQEMGYIFYPRKLR |
| Molecular formula | C101H152N28O22S2 |
| Molecular weight | 2174.6 Da (avg) |
| CAS number | 1627580-64-6 |
| Physical form | Lyophilized powder (typically acetate salt) |
| Verification | Third-party HPLC tested; Certificate of Analysis included |
Reference data for research use only. Confirm identity and purity against the batch Certificate of Analysis.
Sources & References
Peer-reviewed research
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Research FAQ
Compound and research-use information
What is MOTS-c?
MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region. It is supplied as a research chemical for laboratory study.
What is MOTS-c studied for in the research setting?
MOTS-c is studied in vitro and in preclinical models for its role in the AMPK pathway, metabolic-stress signaling, and mitochondrial-to-nuclear communication. It is used as a reference peptide in metabolic-biology research.
What form is Aurevena's MOTS-c supplied in?
MOTS-c is supplied as a lyophilized (freeze-dried) powder. Every batch is tested by independent, accredited U.S. laboratories for purity and identity, with the Certificate of Analysis published on this product page. Store lyophilized peptide cold and protected from light, and avoid repeated freeze-thaw cycles.
Is MOTS-c intended for human use?
No. MOTS-c is sold by Aurevena strictly for laboratory and research use only. It is not a drug, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use, consumption, or for the diagnosis, treatment, cure, or prevention of any disease.





